ImmunityBio Inc. Common Stock is a biotechnology company focused on developing innovative immunotherapies for cancer and infectious diseases. With a diverse portfolio of therapies targeting multiple mechanisms of action, the company is at the forefront of advancing personalized medicine and revolutionizing the treatment landscape.
